ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Washington » Internal Medicine

Top Internal Medicine Prescribers in Washington

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CRAIG ROMNEY MD

Internal Medicine

9,387

$413K

284
221 are 65+

17%
patients receiving schedule two controlled substances

Avg: 7%

27%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$44
Average prescription price

Avg: $56

MADHURINA ROY MD

Internal Medicine

1,404

$71.8K

62
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

35%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $56

NARINDER DUGGAL MD

Internal Medicine

7,030

$928K

277
198 are 65+

30%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$132
Average prescription price

Avg: $56

ALEX NAJERA MD

Internal Medicine

21,723

$1.27M

613
456 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

32%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $56

ELLIS JOHNSON MD

Internal Medicine

11,900

$615K

438
333 are 65+

21%
patients receiving schedule two controlled substances

Avg: 7%

21%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $56

DAWIT GEBREKIDAN M.D.

Internal Medicine

1,050

$44.1K

100
47 are 65+

15%
patients receiving schedule two controlled substances

Avg: 7%

28%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$42
Average prescription price

Avg: $56

SABRINA BENJAMIN MD

Internal Medicine

36,907

$2.23M

857
672 are 65+

23%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $56

KATE CAVENY M.D.

Internal Medicine

644

$36.4K

87
45 are 65+

17%
patients receiving schedule two controlled substances

Avg: 7%

28%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $56

JOSEPH PHANEUF MD

Internal Medicine

3,128

$203K

199
126 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

27%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$65
Average prescription price

Avg: $56

DANIEL LESSLER

Internal Medicine

2,748

$80.6K

65
34 are 65+

28%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$29
Average prescription price

Avg: $56

CHRISTINE MEYERS M.D.

Internal Medicine

849

$19.9K

68
39 are 65+

26%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$23
Average prescription price

Avg: $56

KAREN FAHEY MD

Internal Medicine

4,704

$227K

156
140 are 65+

26%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $56

THOMAS SMITH MD

Internal Medicine

13,726

$2.39M

300
166 are 65+

29%
patients receiving schedule two controlled substances

Avg: 7%

27%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 23%

$174
Average prescription price

Avg: $56

BARBARA WALKER M.D.

Internal Medicine

2,141

$104K

113
106 are 65+

35%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $56

ILIANA MICALI M.D.

Internal Medicine

6,209

$436K

176
138 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

26%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$70
Average prescription price

Avg: $56

BENIGNO WALDO DAGAN MD

Internal Medicine

16,187

$850K

465
353 are 65+

19%
patients receiving schedule two controlled substances

Avg: 7%

24%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $56

AMY EDDY MD

Internal Medicine

1,067

$74.7K

76
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

33%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$70
Average prescription price

Avg: $56

THANH PHAM MD

Internal Medicine

10,400

$575K

433
276 are 65+

22%
patients receiving schedule two controlled substances

Avg: 7%

18%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $56

DEBRA COLE MD

Internal Medicine

3,361

$174K

161
101 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

25%
patients receiving schedule three controlled substances

Avg: 10%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $56

GLENN PACIO MD

Internal Medicine

3,501

$291K

167
137 are 65+

21%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 23%

$83
Average prescription price

Avg: $56

WEIDONG XU

Internal Medicine

12,628

$656K

381
311 are 65+

25%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $56

ANDRE DEJEAN MD

Internal Medicine

2,955

$148K

126
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

33%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $56

JOHN SHEFFIELD

Internal Medicine

3,121

$487K

92
33 are 65+

28%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 23%

$156
Average prescription price

Avg: $56

JOHN HAMILL MD

Internal Medicine

8,193

$617K

300
202 are 65+

21%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$75
Average prescription price

Avg: $56

STEVEN RUDNICK MD

Internal Medicine

13,338

$683K

406
338 are 65+

31%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank